ARTICLE | Top Story
Novartis, Alnylam pandemic flu deal
February 22, 2006 2:23 AM UTC
Novartis (NVS; SWX:NOVN) and ALNY partnered to develop ALNY's RNAi therapeutics for pandemic flu, which are in preclinical development. ALNY expects to submit an IND by year end. Resulting products wi...